Development of a bioorthogonal fluorescence-based assay for assessing drug uptake and delivery in bacteria.

Ooi, Jocelyn M F; Fairhall, Jessica M; Spangler, Benjamin; Chong, Daniel J W; Feng, Brian Y; Gamble, Allan B; Hook, Sarah

Ooi, Jocelyn M F; Fairhall, Jessica M; Spangler, Benjamin; Chong, Daniel J W; Feng, Brian Y; Gamble, Allan B; Hook, Sarah.

Afiliação

Ooi JMF; School of Pharmacy, University of Otago Dunedin New Zealand jess.fairhall@otago.ac.nz sarah.hook@otago.ac.nz.
Fairhall JM; School of Pharmacy, University of Otago Dunedin New Zealand jess.fairhall@otago.ac.nz sarah.hook@otago.ac.nz.
Spangler B; Novartis Institutes for BioMedical Research (NIBR) in Emeryville California USA.
Chong DJW; School of Pharmacy, University of Otago Dunedin New Zealand jess.fairhall@otago.ac.nz sarah.hook@otago.ac.nz.
Feng BY; Novartis Institutes for BioMedical Research (NIBR) in Emeryville California USA.
Gamble AB; School of Pharmacy, University of Otago Dunedin New Zealand jess.fairhall@otago.ac.nz sarah.hook@otago.ac.nz.
Hook S; School of Pharmacy, University of Otago Dunedin New Zealand jess.fairhall@otago.ac.nz sarah.hook@otago.ac.nz.

RSC Adv ; 12(25): 15631-15642, 2022 May 23.

Article em En | MEDLINE | ID: mdl-35685699

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Implementation_research Idioma: En Revista: RSC Adv Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google